Literature DB >> 24337741

T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases.

Kiera L Clayton1, Matthew S Haaland, Matthew B Douglas-Vail, Shariq Mujib, Glen M Chew, Lishomwa C Ndhlovu, Mario A Ostrowski.   

Abstract

CD8(+) CTLs are adept at killing virally infected cells and cancer cells and releasing cytokines (e.g., IFN-γ) to aid this response. However, during cancer and chronic viral infections, such as with HIV, this CTL response is progressively impaired due to a process called T cell exhaustion. Previous work has shown that the glycoprotein T cell Ig and mucin domain-containing protein 3 (Tim-3) plays a functional role in establishing T cell exhaustion. Tim-3 is highly upregulated on virus and tumor Ag-specific CD8(+) T cells, and antagonizing Tim-3 helps restore function of CD8(+) T cells. However, very little is known of how Tim-3 signals in CTLs. In this study, we assessed the role of Tim-3 at the immunological synapse as well as its interaction with proximal TCR signaling molecules in primary human CD8(+) T cells. Tim-3 was found within CD8(+) T cell lipid rafts at the immunological synapse. Blocking Tim-3 resulted in a significantly greater number of stable synapses being formed between Tim-3(hi)CD8(+) T cells and target cells, suggesting that Tim-3 plays a functional role in synapse formation. Further, we confirmed that Tim-3 interacts with Lck, but not the phospho-active form of Lck. Finally, Tim-3 colocalizes with receptor phosphatases CD45 and CD148, an interaction that is enhanced in the presence of the Tim-3 ligand, galectin-9. Thus, Tim-3 interacts with multiple signaling molecules at the immunological synapse, and characterizing these interactions could aid in the development of therapeutics to restore Tim-3-mediated immune dysfunction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337741      PMCID: PMC4214929          DOI: 10.4049/jimmunol.1302663

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.

Authors:  Shariq Mujib; R Brad Jones; Calvin Lo; Nasra Aidarus; Kiera Clayton; Ali Sakhdari; Erika Benko; Colin Kovacs; Mario A Ostrowski
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

2.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 3.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

4.  Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation.

Authors:  Masafumi Nakayama; Hisaya Akiba; Kazuyoshi Takeda; Yuko Kojima; Masaaki Hashiguchi; Miyuki Azuma; Hideo Yagita; Ko Okumura
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

5.  Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.

Authors:  Lucy Golden-Mason; Brent E Palmer; Nasim Kassam; Lisa Townshend-Bulson; Stephen Livingston; Brian J McMahon; Nicole Castelblanco; Vijay Kuchroo; David R Gretch; Hugo R Rosen
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

6.  Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma.

Authors:  Shigeki Katoh; Naoki Ishii; Atsuya Nobumoto; Keisuke Takeshita; Shu-Yan Dai; Rika Shinonaga; Toshiro Niki; Nozomu Nishi; Akira Tominaga; Akira Yamauchi; Mitsuomi Hirashima
Journal:  Am J Respir Crit Care Med       Date:  2007-04-19       Impact factor: 21.405

7.  Role of LAT in the granule-mediated cytotoxicity of CD8 T cells.

Authors:  Chih-wen Ou-Yang; Minghua Zhu; Deirdre M Fuller; Sarah A Sullivan; Mariana I Chuck; Sarah Ogden; Qi-Jing Li; Weiguo Zhang
Journal:  Mol Cell Biol       Date:  2012-05-07       Impact factor: 4.272

8.  Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.

Authors:  Lukas Baitsch; Amandine Legat; Leticia Barba; Silvia A Fuertes Marraco; Jean-Paul Rivals; Petra Baumgaertner; Céline Christiansen-Jucht; Hanifa Bouzourene; Donata Rimoldi; Hanspeter Pircher; Nathalie Rufer; Maurice Matter; Olivier Michielin; Daniel E Speiser
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

9.  Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation.

Authors:  Loïc Dupré; Alessandro Aiuti; Sara Trifari; Silvana Martino; Paola Saracco; Claudio Bordignon; Maria-Grazia Roncarolo
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

10.  TIM-3 does not act as a receptor for galectin-9.

Authors:  Judith Leitner; Armin Rieger; Winfried F Pickl; Gerhard Zlabinger; Katharina Grabmeier-Pfistershammer; Peter Steinberger
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

View more
  41 in total

1.  Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

2.  Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy.

Authors:  Catherine A Sabatos-Peyton; James Nevin; Ansgar Brock; John D Venable; Dewar J Tan; Nasim Kassam; Fangmin Xu; John Taraszka; Luke Wesemann; Thomas Pertel; Nandini Acharya; Max Klapholz; Yassaman Etminan; Xiaomo Jiang; Yu-Hwa Huang; Richard S Blumberg; Vijay K Kuchroo; Ana C Anderson
Journal:  Oncoimmunology       Date:  2017-11-09       Impact factor: 8.110

Review 3.  Galectin-9: From cell biology to complex disease dynamics.

Authors:  Sebastian John; Rashmi Mishra
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

Review 4.  Modulation of regulatory T cell function and stability by co-inhibitory receptors.

Authors:  Liliana E Lucca; Margarita Dominguez-Villar
Journal:  Nat Rev Immunol       Date:  2020-04-08       Impact factor: 53.106

Review 5.  CD8+ T cell exhaustion.

Authors:  Makoto Kurachi
Journal:  Semin Immunopathol       Date:  2019-04-15       Impact factor: 9.623

6.  Impaired functional responses in follicular lymphoma CD8+TIM-3+ T lymphocytes following TCR engagement.

Authors:  Pauline Gravelle; Catherine Do; Camille Franchet; Sabina Mueller; Lucie Oberic; Loïc Ysebaert; Luigi Maria Larocca; Stefan Hohaus; Marie-Noëlle Calmels; François-Xavier Frenois; Robert Kridel; Randy D Gascoyne; Guy Laurent; Pierre Brousset; Salvatore Valitutti; Camille Laurent
Journal:  Oncoimmunology       Date:  2016-08-24       Impact factor: 8.110

Review 7.  Tim-3 and its role in regulating anti-tumor immunity.

Authors:  Madhumita Das; Chen Zhu; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

Review 8.  Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion.

Authors:  Robert L Ferris; Binfeng Lu; Lawrence P Kane
Journal:  J Immunol       Date:  2014-08-15       Impact factor: 5.422

9.  Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

Authors:  Keiko Nagahara; Tomohiro Arikawa; Souichi Oomizu; Keiichi Kontani; Atsuya Nobumoto; Hiroaki Tateno; Kota Watanabe; Toshiro Niki; Shigeki Katoh; Minoru Miyake; Syun-Ichiro Nagahata; Jun Hirabayashi; Vijay K Kuchroo; Akira Yamauchi; Mitsuomi Hirashima
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

Review 10.  Regulation of T cell responses by the receptor molecule Tim-3.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.